Professional Documents
Culture Documents
08 Enzyme Kinetic
08 Enzyme Kinetic
C H A p T er
Enzymes: Kinetics
Peter J. Kennelly, PhD & Victor W. Rodwell, PhD
BIOMEDICAL IMPORTANCE therefore somewhat arbitrary since the products for a reaction
written in one direction are the substrates for the reverse reac-
Enzyme kinetics is the field of biochemistry concerned with tion. The term “products” is, however, often used to designate
the quantitative measurement of the rates of enzyme-catalyzed the reactants whose formation is thermodynamically favored.
reactions and the systematic study of factors that affect these Reactions for which thermodynamic factors strongly favor
rates. A complete, balanced set of enzyme activities is of fun- formation of the products to which the arrow points often are
damental importance for maintaining homeostasis. An under- represented with a single arrow as if they were “irreversible”:
standing of enzyme kinetics, thus, is important to understand-
ing how physiologic stresses such as anoxia, metabolic acidosis A+B →P+Q (2)
or alkalosis, toxins, and pharmacologic agents affect that bal-
ance. Kinetic analysis can reveal the number and order of the Unidirectional arrows are also used to describe reactions
individual steps by which enzymes transform substrates into in living cells where the products of reaction (2) are imme-
products. Together with site-directed mutagenesis and other diately consumed by a subsequent enzyme-catalyzed reac-
techniques that probe protein structure, kinetic analyses can tion. The rapid removal of product P or Q therefore effec-
reveal details of the catalytic mechanism of a given enzyme. tively precludes occurrence of the reverse reaction, rendering
The involvement of enzymes in virtually all physiologic pro- equation (2) functionally irreversible under physiologic
cesses makes them the targets of choice for drugs that cure or conditions.
ameliorate human disease. Applied enzyme kinetics represents
the principal tool by which scientists identify and character- CHANGES IN FREE ENERGY DETERMINE
ize therapeutic agents that selectively inhibit the rates of spe-
cific enzyme-catalyzed processes. Enzyme kinetics thus plays THE DIRECTION & EQUILIBRIUM STATE
a central and critical role in drug discovery and comparative OF CHEMICAL REACTIONS
pharmacodynamics, as well as in elucidating the mode of ac-
The Gibbs free energy change ΔG (also called either the free
tion of drugs.
energy or Gibbs energy) describes both the direction in which
a chemical reaction will tend to proceed and the concentra-
tions of reactants and products that will be present at equilib-
CHEMICAL REACTIONS ARE DESCRIBED rium. ΔG for a chemical reaction equals the sum of the free
USING BALANCED EQUATIONS energies of formation of the reaction products ΔGp minus
the sum of the free energies of formation of the substrates
A balanced chemical equation lists the initial chemical spe-
ΔGs. ΔG0 denotes the change in free energy that accompa-
cies (substrates) present and the new chemical species (prod-
nies transition from the standard state, one-molar concen-
ucts) formed for a particular chemical reaction, all in their
trations of substrates and products, to equilibrium. A more
correct proportions or stoichiometry. For example, balanced
useful biochemical term is ΔG0ʹ, which defines ΔG0 at a stan-
equation (1) below describes the reaction of one molecule each
dard state of 10−7 M protons, pH 7.0 (Chapter 11). If the free
of substrates A and B to form one molecule each of products
energy of formation of the products is lower than that of the
P and Q.
substrates, the signs of ΔG0 and ΔG0ʹ will be negative, indi-
A+B P+Q (1) cating that the reaction as written is favored in the direction
left to right. Such reactions are referred to as spontaneous.
The double arrows indicate reversibility, an intrinsic property The sign and the magnitude of the free energy change de-
of all chemical reactions. Thus, for reaction (1), if A and B can termine how far the reaction will proceed. Equation (3) illus-
form P and Q, then P and Q can also form A and B. Desig- trates the relationship between the equilibrium constant Keq
nation of a particular reactant as a “substrate” or “product” is and ΔG0,
62
CHAPTER 8â•… Enzymes: Kinetics 63
[P][Q]
K eq = (4) O
[A ][B] E O P
o–
–
O
and for reaction (5) OH
A+AP (5) P + Q
from the overall ΔG the number or type of transition states motion and therefore the frequency with which they collide.
through which the reaction proceeds. Stated another way, This combination of more frequent and more highly energetic,
overall thermodynamics tells us nothing about kinetics. and hence productive, collisions increases the reaction rate.
or
Temperature
Raising the temperature increases the kinetic energy of mol- Rate ∝ [A ][B] (17)
2
The sum of the molar ratios of the reactants defines the 4.╇The numeric value of the equilibrium constant Keq can be
kinetic order of the reaction. Consider reaction (5). The stoi- calculated either from the concentrations of substrates and
chiometric coefficient for the sole reactant, A, is two. There- products at equilibrium or from the ratio k1/k−1.
fore, the rate of production of P is proportional to the square
of [A] and the reaction is said to be second order with respect
to reactant A. In this instance, the overall reaction is also sec- THE KINETICS OF ENZYMATIC
ond order. Therefore, k1 is referred to as a second order rate
constant. CATALYSIS
Reaction (12) describes a simple second order reaction
between two different reactants, A and B. The stoichiometric
Enzymes Lower the Activation Energy
coefficient for each reactant is one. Therefore, while the over- Barrier for a Reaction
all order of the reaction is two, it is said to be first order with All enzymes accelerate reaction rates by lowering ΔGF for the
respect to A and first order with respect to B. In the labora- formation of transition states. However, they may differ in the
tory, the kinetic order of a reaction with respect to a particular way this is achieved. Where the mechanism or the sequence
reactant, referred to as the variable reactant or substrate, can of chemical steps at the active site is essentially equivalent
be determined by maintaining the concentration of the other to those for the same reaction proceeding in the absence of
reactants at a constant, or fixed, concentration in large ex- a catalyst, the environment of the active site lowers ΔGF by
cess over the variable reactant. Under these pseudo-first-order stabilizing the transition state intermediates. To put it another
conditions, the concentration of the fixed reactant(s) remains way, the enzyme can be envisioned as binding to the transition
virtually constant. Thus, the rate of reaction will depend exclu- state intermediate (Figure 8–1) more tightly than it does to
sively on the concentration of the variable reactant, sometimes either substrates or products. As discussed in Chapter 7, sta-
also called the limiting reactant. The concepts of reaction or- bilization can involve (1) acid-base groups suitably positioned
der and pseudo-first-order conditions apply not only to simple to transfer protons to or from the developing transition state
chemical reactions but also to enzyme-catalyzed reactions. intermediate, (2) suitably positioned charged groups or metal
ions that stabilize developing charges, or (3) the imposition of
steric strain on substrates so that their geometry approaches
Keq Is a Ratio of Rate Constants that of the transition state. HIV protease (see Figure 7–6) illus-
While all chemical reactions are to some extent reversible, at trates catalysis by an enzyme that lowers the activation barrier
equilibrium the overall concentrations of reactants and prod- by stabilizing a transition state intermediate.
ucts remain constant. At equilibrium, the rate of conversion of Catalysis by enzymes that proceeds via a unique reac-
substrates to products therefore equals the rate at which prod- tion mechanism typically occurs when the transition state
ucts are converted to substrates. intermediate forms a covalent bond with the enzyme (cova-
lent catalysis). The catalytic mechanism of the serine pro-
tease chymotrypsin (see Figure 7–7) illustrates how an en-
Rate1 = Rate −1 (22)
zyme utilizes covalent catalysis to provide a unique reaction
Therefore, pathway.
k1 [A ] [B ] = k −1[P ]
n m
(23) ENZYMES DO NOT AFFECT Keq
and While enzymes may undergo transient modifications during
the process of catalysis, they always emerge unchanged at the
k1 [P ] completion of the reaction. The presence of an enzyme there-
= (24)
[A ] [B] fore has no effect on ΔG0 for the overall reaction, which is
n m
k −1
a function solely of the initial and final states of the reactants.
The ratio of k1 to k−1 is termed the equilibrium constant, Keq. Equation (25) shows the relationship between the equilibrium
The following important properties of a system at equilibrium constant for a reaction and the standard free energy change
must be kept in mind: for that reaction:
1.╇The equilibrium constant is a ratio of the reaction rate (25)
∆G0 = −RT ln K eq
constants (not the reaction rates).
2.╇At equilibrium, the reaction rates (not the rate constants) of
This principle is perhaps most readily illustrated by includ-
the forward and back reactions are equal.
ing the presence of the enzyme (Enz) in the calculation of the
3.╇Equilibrium is a dynamic state. Although there is no net
equilibrium constant for an enzyme-catalyzed reaction:
change in the concentration of substrates or products,
individual substrate and product molecules are continually
being interconverted. A + B + Enz P + Q + Enz (26)
66 SECTION Iâ•… Structures & Functions of Proteins & Enzymes
[P][Q] 0
Low High
K eq = (28)
[A ][B] pH
Enzymes therefore have no effect on Keq. FIGURE 8–3Â�╇ Effect of pH on enzyme activity. Consider, for
example, a negatively charged enzyme (E−) that binds a positively
charged substrate (SH+). Shown is the proportion (%) of SH+ [\\\] and
of E− [///] as a function of pH. Only in the cross-hatched area do both
MULTIPLE FACTORS AFFECT THE RATES the enzyme and the substrate bear an appropriate charge.
OF ENZYME-CATALYZED REACTIONS
Temperature
Raising the temperature increases the rate of both uncatalyzed enzyme denaturation at high or low pH and effects on the
and enzyme-catalyzed reactions by increasing the kinetic en- charged state of the enzyme, the substrates, or both. For en-
ergy and the collision frequency of the reacting molecules. zymes whose mechanism involves acid-base catalysis, the
However, heat energy can also increase the kinetic energy of residues involved must be in the appropriate state of protona-
the enzyme to a point that exceeds the energy barrier for dis- tion for the reaction to proceed. The binding and recognition
rupting the noncovalent interactions that maintain its three- of substrate molecules with dissociable groups also typically
dimensional structure. The polypeptide chain then begins to involves the formation of salt bridges with the enzyme. The
unfold, or denature, with an accompanying loss of catalytic most common charged groups are carboxylate groups (nega-
activity. The temperature range over which an enzyme main- tive) and protonated amines (positive). Gain or loss of critical
tains a stable, catalytically competent conformation depends charged groups adversely affects substrate binding and thus
upon—and typically moderately exceeds—the normal tem- will retard or abolish catalysis.
perature of the cells in which it resides. Enzymes from humans
generally exhibit stability at temperatures up to 45–55°C. By
contrast, enzymes from the thermophilic microorganisms that ASSAYS OF ENZYME-CATALYZED
reside in volcanic hot springs or undersea hydrothermal vents REACTIONS TYPICALLY MEASURE
may be stable up to or even above 100°C.
The Q10, or temperature coefficient, is the factor by which
THE INITIAL VELOCITY
the rate of a biologic process increases for a 10°C increase in tem- Most measurements of the rates of enzyme-catalyzed reactions
perature. For the temperatures over which enzymes are stable, employ relatively short time periods, conditions that approxi-
the rates of most biologic processes typically double for a 10°C mate initial rate conditions. Under these conditions, only
rise in temperature (Q10 = 2). Changes in the rates of enzyme- traces of product accumulate, rendering the rate of the reverse
catalyzed reactions that accompany a rise or fall in body temper- reaction negligible. The initial velocity (vi) of the reaction thus
ature constitute a prominent survival feature for “cold-blooded” is essentially that of the rate of the forward reaction. Assays of
life forms such as lizards or fish, whose body temperatures are enzyme activity almost always employ a large (103–107) molar
dictated by the external environment. However, for mammals excess of substrate over enzyme. Under these conditions, vi is
and other homeothermic organisms, changes in enzyme reac- proportionate to the concentration of enzyme. Measuring the
tion rates with temperature assume physiologic importance initial velocity therefore permits one to estimate the quantity
only in circumstances such as fever or hypothermia. of enzyme present in a biologic sample.
equal validity. Moreover, by employing pseudo-first-order forming ES, further increases in [S] cannot increase the rate
conditions (see above), scientists can study the dependence of of the reaction. Under these saturating conditions, vi depends
reaction rate upon an individual reactant through the appro- solely on—and thus is limited by—the rapidity with which
priate choice of fixed and variable substrates. In other words, product dissociates from the enzyme so that it may combine
under pseudo-first-order conditions the behavior of a multi- with more substrate.
substrate enzyme will imitate one having a single substrate,
In this instance, however, the observed rate constant will be a
function of the rate constant k1 for the reaction as well as the THE MICHAELIS-MENTEN & HILL
concentration of the fixed substrate(s).
For a typical enzyme, as substrate concentration is in-
EQUATIONS MODEL THE EFFECTS
creased, vi increases until it reaches a maximum value Vmax OF SUBSTRATE CONCENTRATION
(Figure 8–4). When further increases in substrate concentra-
tion do not further increase vi, the enzyme is said to be “sat- The Michaelis-Menten Equation
urated” with substrate. Note that the shape of the curve that The Michaelis-Menten equation (29) illustrates in mathematical
relates activity to substrate concentration (Figure 8–4) is hy- terms the relationship between initial reaction velocity vi and
perbolic. At any given instant, only substrate molecules that substrate concentration [S], shown graphically in Figure 8–4.
are combined with the enzyme as an ES complex can be trans-
formed into product. Second, the equilibrium constant for the Vmax [S]
formation of the enzyme-substrate complex is not infinitely vi = (29)
K m + [S ]
large. Therefore, even when the substrate is present in excess
(points A and B of Figure 8–5), only a fraction of the enzyme The Michaelis constant Km is the substrate concentration at
may be present as an ES complex. At points A or B, increas- which vi is half the maximal velocity (Vmax/2) attainable at a
ing or decreasing [S] therefore will increase or decrease the particular concentration of enzyme. Km thus has the di�men�
number of ES complexes with a corresponding change in vi. sions of substrate concentration. The dependence of initial re-
At point C (Figure 8–5), essentially all the enzyme is present action velocity on [S] and Km may be illustrated by evaluating
as the ES complex. Since no free enzyme remains available for the Michaelis-Menten equation under three conditions.
1. When [S] is much less than Km (point A in Figures 8–4
& 8–5), the term Km + [S] is essentially equal to Km. Replacing
Km + [S] with Km reduces equation (29) to
=S
=E
A B C
FIGURE 8–5╇ Representation of an enzyme in the presence of a concentration of substrate that is below Km
(A), at a concentration equal to Km (B), and at a concentration well above Km(C). Points A, B, and C correspond to
those points in Figure 8–4.
68 SECTION Iâ•… Structures & Functions of Proteins & Enzymes
0 1
Thus, when [S] greatly exceeds Km, the reaction velocity [S]
is maximal (Vmax) and unaffected by further increases in sub-
strate concentration. FIGURE 8–6╇ Double-reciprocal or Lineweaver-Burk plot of 1/vi
versus 1/[S] used to evaluate Km and Vmax.
3. When [S] = Km (point B in Figures 8–4 & 8–5).
Equation (32) states that when [S] equals Km, the initial ve- Km is thus most readily calculated from the negative x inter-
locity is half-maximal. Equation (32) also reveals that Km is— cept.
and may be determined experimentally from—the substrate The greatest virtue of the Lineweaver-Burk plot resides in
concentration at which the initial velocity is half-maximal. the facility with which it can be used to determine the kinetic
mechanisms of enzyme inhibitors (see below). However, in us-
ing a double-reciprocal plot to determine kinetic constants, it
A Linear Form of the Michaelis-Menten
is important to avoid the introduction of bias through the clus-
Equation Is Used to Determine Km & Vmax tering of data at low values of 1/[S]. To achieve this, prepare a
The direct measurement of the numeric value of Vmax, and solution of substrate whose dilution into an assay will produce
therefore the calculation of Km, often requires impractically the maximum desired concentration of substrate. Now use the
high concentrations of substrate to achieve saturating condi- same volume of solutions prepared by diluting the stock solu-
tions. A linear form of the Michaelis-Menten equation circum- tion by factors of 1:2, 1:3, 1:4, 1:5, etc. The data will then fall
vents this difficulty and permits Vmax and Km to be extrapolated on the 1/[S] axis at intervals of 1, 2, 3, 4, 5, etc. Alternatively,
from initial velocity data obtained at less than saturating con- a single-reciprocal plot such as the Eadie-Hofstee (vi versus
centrations of substrate. Start with equation (29), vi/[S]) or Hanes-Woolf ([S]/vi versus [S]) plot can be used to
minimize clustering.
Vmax [S]
vi = (29)
K m + [S ]
The Catalytic Constant, kcat
invert Several parameters may be used to compare the relative activity
of different enzymes, or of different preparations of the same
1 K m + [S ]
= (33) enzyme. The activity of impure enzyme preparations typically
vi Vmax [S] is expressed as specific activity (Vmax divided by the protein
concentration). For a homogeneous enzyme one may calcu-
factor
late its turnover number (Vmax divided by the moles of enzyme
1 Km [S ] present). But if the number of active sites present is known, the
= + (34) catalytic activity of a homogeneous enzyme is best expressed
vi Vmax [S ] Vmax [S ]
as its catalytic constant, kcat (Vmax divided by the number active
and simplify sites, St).
Vmax
1 Km 1 1 k cat = (37)
= + (35) St
vi Vmax [S] Vmax
Since the units of concentration cancel out, the units of kcat are
Equation (35) is the equation for a straight line, y = ax + b, reciprocal time.
where y = 1/vi and x = 1/[S]. A plot of 1/vi as y as a function of
1/[S] as x therefore gives a straight line whose y intercept is 1/
Vmax and whose slope is Km/Vmax. Such a plot is called a double- Catalytic Efficiency, kcat/Km
reciprocal or Lineweaver-Burk plot (Figure 8–6). Setting the By what measure should the efficiency of different enzymes,
y term of equation (36) equal to zero and solving for x reveals different substrates for a given enzyme, and the efficiency
that the x intercept is −1/Km. with which an enzyme catalyzes a reaction in the forward and
CHAPTER 8â•… Enzymes: Kinetics 69
k −1 + k 2
[S ] = = Km (41)
k1
0 [S] ∞
When k−1 >>k2, then
FIGURE 8–7╇ Representation of sigmoid substrate saturation
k −1 + k 2 ≈ k −1 (42) kinetics.
70 SECTION Iâ•… Structures & Functions of Proteins & Enzymes
0 Slope = n
The effects of competitive inhibitors can be overcome by rais-
ing the concentration of substrate. Most frequently, in compet-
itive inhibition the inhibitor (I) binds to the substrate-binding
Log
Double-Reciprocal Plots Facilitate the For simple noncompetitive inhibition, E and EI possess
identical affinity for substrate, and the EIS complex generates
Evaluation of Inhibitors
product at a negligible rate (Figure 8–11). More complex non-
Double-reciprocal plots distinguish between competitive and competitive inhibition occurs when binding of the inhibitor
noncompetitive inhibitors and simplify evaluation of inhibi- does affect the apparent affinity of the enzyme for substrate,
tion constants. vi is determined at several substrate concen- causing the lines to intercept in either the third or fourth quad-
trations both in the presence and in the absence of inhibitor. rants of a double-reciprocal plot (not shown). While certain
For classic competitive inhibition, the lines that connect the inhibitors exhibit characteristics of a mixture of competitive
experimental data points converge at the y-axis (Figure 8–10). and noncompetitive inhibition, the evaluation of these inhibi-
Since the y intercept is equal to 1/Vmax, this pattern indicates tors exceeds the scope of this chapter.
that when 1/[S] approaches 0, vi is independent of the pres-
ence of inhibitor. Note, however, that the intercept on the x-
axis does vary with inhibitor concentration—and that since Dixon Plot
−1/Kʹm is smaller than 1/Km, Kʹm (the “apparent Km”) becomes A Dixon plot is sometimes employed as an alternative to the
larger in the presence of increasing concentrations of the in- Lineweaver-Burk plot for determining inhibition constants.
hibitor. Thus, a competitive inhibitor has no effect on Vmax The initial velocity (vi) is measured at several concentrations
but raises Kʹm, the apparent Km for the substrate. For simple of inhibitor, but at a fixed concentration of substrate (S). For
competitive inhibition, the intercept on the x-axis is a simple competitive or noncompetitive inhibitor, a plot of
1/vi versus inhibitor concentration [I] yields a straight line.
−1 [I] The experiment is repeated at different fixed concentrations of
x = 1 + (47) substrate. The resulting set of lines intersects to the left of the
Km Ki
y-axis. For competitive inhibition, a perpendicular dropped to
the negative x-axis from the point of intersection of the lines
Once Km has been determined in the absence of inhibitor,
gives −Ki (Figure 8–12, top). For noncompetitive inhibition the
Ki can be calculated from equation (47). Ki values are used to
intercept on the negative x-axis is −Ki (Figure 8–12, bottom).
compare different inhibitors of the same enzyme. The lower
Pharmaceutical publications frequently employ Dixon plots to
the value for Ki, the more effective the inhibitor. For example,
evaluate the comparative potency of competitive inhibitors.
the statin drugs that act as competitive inhibitors of HMG-
CoA reductase (Chapter 26) have Ki values several orders of
magnitude lower than the Km for the substrate HMG-CoA. IC50
A less rigorous, but frequently used, alternative to Ki as a mea-
Simple Noncompetitive Inhibitors Lower sure of inhibitory potency is the concentration of inhibitor
that produces 50% inhibition, IC50. Unlike the equilibrium
Vmax But Do Not Affect Km dissociation constant Ki, the numeric value of IC50 varies as a
In noncompetitive inhibition, binding of the inhibitor does function of the specific circumstances of substrate concentra-
not affect binding of substrate. Formation of both EI and EIS tion, etc., under which it is determined.
complexes is therefore possible. However, while the enzyme-
inhibitor complex can still bind substrate, its efficiency at
transforming substrate to product, reflected by Vmax, is de- Tightly Bound Inhibitors
creased. Noncompetitive inhibitors bind enzymes at sites dis- Some inhibitors bind to enzymes with such high affinity, Ki ≤
tinct from the substrate-binding site and generally bear little 10−9 M, that the concentration of inhibitor required to measure
or no structural resemblance to the substrate. Ki falls below the concentration of enzyme typically present in
1
vi
r
to
bi
hi
In
tor
hibi
+
in
– K1′ No
m
– 1 1
Km Vmax
0 1
[S]
FIGURE 8–10╇ Lineweaver-Burk plot of competitive inhibition. FIGURE 8–11╇ Lineweaver-Burk plot for simple noncompetitive
Note the complete relief of inhibition at high [S] (ie, low 1/[S]). inhibition.
72 SECTION Iâ•… Structures & Functions of Proteins & Enzymes
[S]
MOST ENZYME-CATALYZED REACTIONS
INVOLVE TWO OR MORE SUBSTRATES
While many enzymes have a single substrate, many others
have two—and sometimes more—substrates and products.
-Ki [I]
The fundamental principles discussed above, while illustrated
FIGURE 8–12╇ Applications of Dixon plots. Top: Competitive for single-substrate enzymes, apply also to multisubstrate en-
inhibition, estimation of Ki. Bottom: Noncompetitive inhibition, zymes. The mathematical expressions used to evaluate mul-
estimation of Ki. tisubstrate reactions are, however, complex. While a detailed
analysis of the full range of multisubstrate reactions exceeds
the scope of this chapter, some common types of kinetic be-
havior for two-substrate, two-product reactions (termed “Bi-
an assay. Under these circumstances a significant fraction of the
Bi” reactions) are considered below.
total inhibitor may be present as an EI complex. If so, this vio-
lates the assumption, implicit in classical steady-state kinetics,
that the concentration of free inhibitor is independent of the Sequential or Single-Displacement
concentration of enzyme. The kinetic analysis of these tightly
bound inhibitors requires specialized kinetic equations that
Reactions
incorporate the concentration of enzyme to estimate Ki or IC50 In sequential reactions, both substrates must combine with
and to distinguish competitive from noncompetitive tightly the enzyme to form a ternary complex before catalysis can
bound inhibitors. proceed (Figure 8–13, top). Sequential reactions are some-
times referred to as single-displacement reactions because the
group undergoing transfer is usually passed directly, in a sin-
Irreversible Inhibitors “Poison” Enzymes gle step, from one substrate to the other. Sequential Bi-Bi reac-
In the above examples, the inhibitors form a dissociable, dy- tions can be further distinguished on the basis of whether the
namic complex with the enzyme. Fully active enzyme can two substrates add in a random or in a compulsory order. For
therefore be recovered simply by removing the inhibitor from random-order reactions, either substrate A or substrate B may
the surrounding medium. However, a variety of other in- combine first with the enzyme to form an EA or an EB com-
hibitors act irreversibly by chemically modifying the enzyme. plex (Figure 8–13, center). For compulsory-order reactions, A
These modifications generally involve making or breaking co- must first combine with E before B can combine with the EA
valent bonds with aminoacyl residues essential for substrate complex. One explanation for a compulsory-order mechanism
binding, catalysis, or maintenance of the enzyme’s functional is that the addition of A induces a conformational change in
conformation. Since these covalent changes are relatively the enzyme that aligns residues that recognize and bind B.
stable, an enzyme that has been “poisoned” by an irreversible
inhibitor such as a heavy metal atom or an acylating reagent
remains inhibited even after removal of the remaining inhibi- Ping-Pong Reactions
tor from the surrounding medium. The term “ping-pong” applies to mechanisms in which one
or more products are released from the enzyme before all
the substrates have been added. Ping-pong reactions involve
Mechanism-Based Inhibition covalent catalysis and a transient, modified form of the en-
“Mechanism-based” or “suicide” inhibitors are specialized zyme (see Figure 7–4). Ping-pong Bi-Bi reactions are double
substrate analogs that contain a chemical group that can be displacement reactions. The group undergoing transfer is
transformed by the catalytic machinery of the target enzyme. first displaced from substrate A by the enzyme to form prod-
After binding to the active site, catalysis by the enzyme gen- uct P and a modified form of the enzyme (F). The subsequent
CHAPTER 8â•… Enzymes: Kinetics 73
A B P Q Increasing
[S2]
E EA EAB-EPQ EQ E
A B P Q
EA EQ 1
vi
E EAB-EPQ E
EB EP
B A Q P
A P B Q
1
[S1]
E EA-FP F FB-EQ E
FIGURE 8–14╇ Lineweaver-Burk plot for a two-substrate ping-
FIGURE 8–13╇ Representations of three classes of Bi-Bi reaction pong reaction. An increase in concentration of one substrate (S1)
mechanisms. Horizontal lines represent the enzyme. Arrows indicate
while that of the other substrate (S2) is maintained constant changes
the addition of substrates and departure of products. Top: An
both the x and y intercepts, but not the slope.
ordered Bi-Bi reaction, characteristic of many NAD(P)H-dependent
oxidoreductases. Center: A random Bi-Bi reaction, characteristic of
many kinases and some dehydrogenases. Bottom: A ping-pong nations of product inhibitor and variable substrate will pro-
reaction, characteristic of aminotransferases and serine proteases. duce forms of complex noncompetitive inhibition.
group transfer from F to the second substrate B, forming prod- KNOWLEDGE OF ENZYME KINETICS,
uct Q and regenerating E, constitutes the second displacement MECHANISM, AND INHIBITION AIDS
(Figure 8–13, bottom).
DRUG DEVELOPMENT
Most Bi-Bi Reactions Conform to Many Drugs Act as Enzyme Inhibitors
Michaelis-Menten Kinetics The goal of pharmacology is to identify agents that can
Most Bi-Bi reactions conform to a somewhat more complex 1.╇Destroy or impair the growth, invasiveness, or
form of Michaelis-Menten kinetics in which Vmax refers to development of invading pathogens
the reaction rate attained when both substrates are present 2.╇ Stimulate endogenous defense mechanisms
at saturating levels. Each substrate has its own characteristic 3.╇Halt or impede aberrant molecular processes triggered by
Km value, which corresponds to the concentration that yields genetic, environmental, or biologic stimuli with minimal
half-maximal velocity when the second substrate is present perturbation of the host’s normal cellular functions.
at saturating levels. As for single-substrate reactions, double- By virtue of their diverse physiologic roles and high degree
reciprocal plots can be used to determine Vmax and Km. vi is of substrate selectivity, enzymes constitute natural targets for
measured as a function of the concentration of one substrate the development of pharmacologic agents that are both potent
(the variable substrate) while the concentration of the other and specific. Statin drugs, for example, lower cholesterol pro-
substrate (the fixed substrate) is maintained constant. If the duction by inhibiting 3-hydroxy-3-methylglutaryl coenzyme
lines obtained for several fixed-substrate concentrations are A reductase (Chapter 26), while emtricitabine and tenofovir
plotted on the same graph, it is possible to distinguish be- disoproxil fumarate block replication of the human immuno-
tween a ping-pong enzyme, which yields parallel lines, and a deficiency virus by inhibiting the viral reverse transcriptase
sequential mechanism, which yields a pattern of intersecting (Chapter 34). Pharmacologic treatment of hypertension often
lines (Figure 8–14). includes the administration of an inhibitor of angiotensin-
Product inhibition studies are used to complement kinet- converting enzyme, thus lowering the level of angiotensin II, a
ic analyses and to distinguish between ordered and random vasoconstrictor (Chapter 42).
Bi-Bi reactions. For example, in a random-order Bi-Bi reac-
tion, each product will be a competitive inhibitor regardless of
which substrate is designated the variable substrate. However,
Enzyme Kinetics Defines Appropriate
for a sequential mechanism (Figure 8–13, top), only product Q Screening Conditions
will give the pattern indicative of competitive inhibition when Enzyme kinetics plays a crucial role in drug discovery. Knowl-
A is the variable substrate, while only product P will produce edge of the kinetic behavior of the enzyme of interest is
this pattern with B as the variable substrate. The other combi- necessary, first and foremost, to select appropriate assay con-
74 SECTION Iâ•… Structures & Functions of Proteins & Enzymes
ditions that readily detect the presence of an inhibitor. The n Measurement of the rate of an enzyme-catalyzed reaction
concentration of substrate, for example, must be adjusted such generally employs initial rate conditions, for which the essential
that sufficient product is generated to permit facile detection absence of product precludes the reverse reaction.
of the enzyme’s activity without being so high that it masks the n Linear forms of the Michaelis-Menten equation simplify
presence of an inhibitor. Second, enzyme kinetics provides the determination of Km and Vmax.
means for quantifying and comparing the potency of different n A linear form of the Hill equation is used to evaluate the
inhibitors and defining their mode of action. Noncompetitive cooperative substrate-binding kinetics exhibited by some
inhibitors are particularly desirable, because—by contrast to multimeric enzymes. The slope n, the Hill coefficient, reflects
the number, nature, and strength of the interactions of the
competitive inhibitors—their effects can never be completely
substrate-binding sites. A value of n greater than 1 indicates
overcome by increases in substrate concentration.
positive cooperativity.
n The effects of simple competitive inhibitors, which typically
Many Drugs Are Metabolized In Vivo resemble substrates, are overcome by raising the concentration
of the substrate. Simple noncompetitive inhibitors lower Vmax
Drug development often involves more than the kinetic evalu- but do not affect Km.
ation of the interaction of inhibitors with the target enzyme.
n For simple competitive and noncompetitive inhibitors, the
Drugs are acted upon by enzymes present in the patient or inhibitory constant Ki is equal to the equilibrium dissociation
pathogen, a process termed drug metabolism. For example, constant for the relevant enzyme-inhibitor complex. A simpler
penicillin and other β-lactam antibiotics block cell wall syn- and less rigorous term for evaluating the effectiveness of an
thesis in bacteria by irreversibly poisoning the enzyme alanyl inhibitor is IC50, the concentration of inhibitor that produces
alanine carboxypeptidase-transpeptidase. Many bacteria, how- 50% inhibition under the particular circumstances of the
ever, produce β-lactamases that hydrolyze the critical β-lactam experiment.
function in penicillin and related drugs. One strategy for over- n Substrates may add in a random order (either substrate may
coming the resulting antibiotic resistance is to simultaneously combine first with the enzyme) or in a compulsory order
administer a β-lactamase inhibitor and a β-lactam antibiotic. (substrate A must bind before substrate B).
Metabolic transformation is also required to convert an n In ping-pong reactions, one or more products are released from
inactive drug precursor, or prodrug, into its biologically active the enzyme before all the substrates have been added.
form (Chapter 53). 2ʹ-Deoxy-5-fluorouridylic acid, a potent n Applied enzyme kinetics facilitates the identification and
inhibitor of thymidylate synthase, a common target of cancer characterization of drugs that selectively inhibit specific
chemotherapy, is produced from 5-fluorouracil via a series enzymes. Enzyme kinetics thus plays a central and critical role
of enzymatic transformations catalyzed by a phosphoribosyl in drug discovery, in comparative pharmacodynamics, and in
transferase and the enzymes of the deoxyribonucleoside sal- determining the mode of action of drugs.
vage pathway (Chapter 33). Effective design and administra-
tion of prodrugs requires knowledge of the kinetics and mech-
anisms of the enzymes responsible for transforming them into REFERENCES
their biologically active forms. Dixon M: The determination of enzyme inhibitor constants.
Biochem J 1953;55:170.
Dixon M: The graphical determination of Km and Ki. Biochem J
SUMMARY 1972;129:197.
Fersht A: Structure and Mechanism in Protein Science: A Guide to
n The study of enzyme kinetics—the factors that affect the rates
Enzyme Catalysis and Protein Folding. Freeman, 1999.
of enzyme-catalyzed reactions—reveals the individual steps by
Fraser CM, Rappuoli R: Application of microbial genomic science to
which enzymes transform substrates into products.
advanced therapeutics. Annu Rev Med 2005;56:459.
n ΔG, the overall change in free energy for a reaction, is Henderson PJF: A linear equation that describes the steady-state
independent of reaction mechanism and provides no kinetics of enzymes and subcellular particles interacting with
information concerning rates of reactions. tightly bound inhibitors. Biochem J 1972;127:321.
n Enzymes do not affect Keq. Keq, a ratio of reaction rate constants, Schramm, VL: Enzymatic transition-state theory and transition-
may be calculated from the concentrations of substrates and state analogue design. J Biol Chem 2007;282:28297.
products at equilibrium or from the ratio k1/k−1. Schultz AR: Enzyme Kinetics: From Diastase to Multi-enzyme
n Reactions proceed via transition states in which ΔGF is the Systems. Cambridge University Press, 1994.
activation energy. Temperature, hydrogen ion concentration, Segel IH: Enzyme Kinetics. Wiley Interscience, 1975.
enzyme concentration, substrate concentration, and inhibitors Wlodawer A: Rational approach to AIDS drug design through
all affect the rates of enzyme-catalyzed reactions. structural biology. Annu Rev Med 2002;53:595.